• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Delhi govt committee suggests cap on 'exhorbitant' profit margins of pvt hospitals

By Vikas
|

After a series of a case brought to fore the exorbitant rates charged by the private hospitals in the national capital, a committee, formed by the Delhi government, has suggested norms that would put a cap on these rates.

Image for representation only

One of the important recommendations is that private hospitals should only prescribe from the list of 376 drugs on the National List of Essential Medicines (NLEM), said an HT report.

In case of diagnostic tests, the committee has recommended that labs and hospitals must not charge a premium of more than 15% over market rates.

If the hospital has to prescribe a drug which is not on the National List of Essential Medicines, the hospitals must not charge a profit of not more than 50% on the procurement price. It must be noted that profit mentioned in the committee's recommendation is not calculated based on the MRP, but on procurement price.

Professor Vijay Bhalla, the director, SGT College of Pharmacy, Gurgaon, welcomed the recommendations and said that "This will make a huge difference."

"The drug price control orders fix the rates of NLEM drugs by calculating a market average of the selling price of drugs in a particular category, ensuring some profit for manufacturers but not too much," an HT report quoted Bhalla as saying.

Last year in September, 7-year-old girl, Adya, was treated for dengue in Fortis Memorial Gurgaon and the family was given a bill that went into lakhs. The girl eventually died. An investigation into this particular case by the National Pharmaceutical Pricing Authority (NPPA) revealed that the hospital made a profit of more than 1,700% on drugs and consumables used for the treatment.

OneIndia News

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more